Search the Newsreel

electroCore Q2 Earnings Call Highlights

electroCore (NASDAQ:ECOR) reported a 28% year-over-year revenue increase to $9.5 million for Q2 2026, driven by strong Veterans Affairs prescription sales and direct-to-consumer Truvaga demand. The company raised its full-year outlook to over 30% growth and aims for positive adjusted EBITDA by Q3 2027 …

Earnings call transcript: electroCore posts Q2 2026 EPS beat, raises outlook

electroCore Announces Second Quarter 2026 Financial Results

electroCore announced strong second-quarter 2026 financial results, with net sales increasing by 28% to $9.5 million, driven by growth in U.S. prescription sales and Truvaga sales. The company reduced its net loss by 17% and improved Adjusted EBITDA by 26% year-over-year. electroCore also raised …

[10-Q] electroCore, Inc. Quarterly Earnings Report

electroCore, Inc. (ECOR) filed its quarterly earnings report (Form 10-Q) for the period ending June 30, 2026, revealing funding shortfalls and raising substantial doubt about its ability to continue as a going concern. The company reported a net loss of $8.3 million for the …

electroCore (NASDAQ: ECOR) lifts 2026 outlook after 28% Q2 growth

electroCore's Quell Sales Reach $1.3M, Up About 700%

Why Floor & Decor (FND) Is Up 12.4% After Raising 2026 Earnings Guidance And Boosting Buybacks

In the past week, Floor & Decor Holdings, Inc. reported second-quarter 2026 results showing sales of US$1,250.27 million and net income of US$95.87 million, alongside updated full-year guidance calling for US$4.77 billion–US$4.99 billion in net sales and diluted EPS of US$2.20–US$2.45. Management highlighted stronger …

electroCore, Inc. (ECOR) Reports Q2 Loss, Tops Revenue Estimates

electroCore, Inc. (ECOR) reported a Q2 loss of $0.33 per share, exceeding the Zacks Consensus Estimate of a $0.41 loss, and posted revenues of $9.45 million, surpassing estimates by 0.92%. The company's stock has gained 45.6% year-to-date, outperforming the S&P 500. Currently, electroCore holds …

Quebecor Q2 2026 Earnings Call Transcript

Floor & Decor (FND) Is Up 12.4% After Raising 2026 Guidance and Highlighting Pro Customer Momentum

Floor & Decor (NYSE: FND) EVP withholds 907 shares for tax obligation

John J Adamson, EVP & CIO of Floor & Decor Holdings, Inc. (NYSE: FND), reported a tax-withholding disposition of 907 shares of Class A common stock on August 5, 2026. This transaction involved surrendering restricted stock to cover tax obligations upon vesting, rather than …

QUEBECOR INC CLASS B SV (QBR-B.TO) Q2 FY2026 earnings call transcript

Quebecor Q2 Earnings Miss Estimates Despite Revenue Beat

Earnings Flash (QBR.A, QBR.B) Quebecor Inc. Reports Q2 Revenue C$1.44B, vs. FactSet Est of C$1.42B

QUEBECOR INC. REPORTS CONSOLIDATED RESULTS FOR SECOND QUARTER 2026

MONTRÉAL, Aug. 6, 2026 /CNW/ -- Quebecor Inc. ("Quebecor" or "the Corporation") today reported its consolidated financial results for the second quarter of 2026. Second quarter 2026 highlights In the second quarter of 2026, Quebecor's free cash flows1 were up $43.8 million (11.7%) compared …

TransMedics Group (TMDX) Stock Faces Margin Pressure After Record Revenue

ECOR Looks 25.1% Undervalued on GF Value™ Despite Revenue Miss

Lifecore Biomedical Releases Q2 2026 Financial Results

Lifecore Biomedical, Inc. (LFCR) reported its Q2 2026 financial results, narrowing its loss per share to -$0.19 and exceeding revenue expectations with $34.2 million. Despite beating estimates, the company experienced a 6.2% revenue decline year-over-year due to softness in its CDMO segment. Management provided …

Lifecore Biomedical (NASDAQ:LFCR) Releases Quarterly Earnings Results, Beats Estimates By $0.03 EPS

Lifecore Biomedical (NASDAQ:LFCR) reported its quarterly earnings, exceeding analyst estimates with an EPS loss of $0.19, $0.03 better than expected, and revenue of $34.17 million, surpassing the $32.02 million forecast. Despite a year-to-date revenue decline and widened net loss, the company reaffirmed its 2026 …

LFCR Stock Price and Chart — NASDAQ:LFCR

Lifecore Biomedical, Inc. (LFCR) is a pharmaceutical company specializing in hyaluronan-based products. Its stock price is currently $5.01, with a market capitalization of $189.64 million. The company's recent earnings report showed declining revenue and profit year-over-year, but management reaffirmed 2026 guidance due to cost …

Lifecore Biomedical Inc expected to post a loss of 22 cents a share - Earnings Preview

Lifecore Biomedical Inc is anticipated to report a loss of 22 cents per share, according to an earnings preview. This forecast is based on information shared through TradingView News, indicating an upcoming financial announcement for the company.

Lifecore Biomedical, Inc. reports results for the quarter ended June 30 - Earnings Summary

Lifecore Biomedical, Inc. has reported its financial results for the quarter that ended on June 30. The article, sourced from Reuters via TradingView News, provides an earnings summary for the company. Readers are encouraged to access the full report for detailed information.

Lifecore Biomedical Q2 FY26 net loss widens to $6.2 million; revenue falls 6.2% to $34.2 million

Lifecore Biomedical reported a wider GAAP net loss of $6.2 million in Q2 FY26, with revenue decreasing by 6.2% to $34.2 million. GAAP gross profit also fell, and non-GAAP adjusted EBITDA saw a slight decrease. Despite these financial challenges, the company signed six new …

Lifecore Signs Six New Programs, Including Two Commercial-Stage

Lifecore Biomedical reported Q2 2026 revenues of $34.2 million, a 6.2% decrease year-over-year, and a net loss of $6.2 million. Despite the revenue decline, the company reaffirmed its 2026 guidance for revenues of $120–$125 million and Adjusted EBITDA of $20.5–$25 million, citing strong business …

Lifecore Biomedical (NASDAQ: LFCR) Q2 revenue slips as 2026 guidance reaffirmed

Lifecore Biomedical reported a decline in Q2 2026 revenue to $34.2 million and an increased net loss of $6.2 million, despite growth in hyaluronic-acid manufacturing. The company reaffirmed its full-year 2026 guidance for revenue ($120-$125 million) and Adjusted EBITDA ($20.5-$25 million), highlighting a strong …

Lifecore Biomedical, Inc. Reaffirms Earnings Guidance for the Calendar Year 2026

Lifecore Biomedical, Inc. has reaffirmed its earnings guidance for the calendar year 2026, expecting revenue to be in the range of $120 million to $125 million. This announcement was made on August 5, 2026, coinciding with their Q2 2026 earnings call. The company specializes …

Floor & Decor Holdings (FND) Earnings And Raised Guidance Put Fair Value In Focus

ECOR Looks 32.3% Undervalued on GF Value™ Amid Price-to-Sales Co

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lifecore

Faruqi & Faruqi, LLP is investigating potential securities claims against Lifecore Biomedical, Inc. (NASDAQ: LFCR) on behalf of investors who suffered losses exceeding $75,000 between October 7, 2020, and March 19, 2024. The investigation stems from allegations that Lifecore made false or misleading statements …

electroCore to Participate in Upcoming Investor Conferences

electroCore, Inc. (Nasdaq: ECOR) announced that its management will participate in two upcoming investor conferences: the Needham 11th Annual Virtual MedTech and Diagnostics Conference on August 11, 2026, and the Canaccord Genuity 46th Annual Growth Conference on August 11-12, 2026. Management will host one-on-one …

Floor & Decor: Better Demand Is Not Yet A Durable Earnings Recovery (NYSE:FND)

Floor & Decor Holdings, Inc. $FND Shares Purchased by Carlson Capital L.P.

Carlson Capital L.P. significantly increased its stake in Floor & Decor Holdings, Inc. (NYSE:FND) during the first quarter, purchasing an additional 24,278 shares to bring its total to 36,478 shares valued at $1.85 million. This increased holding comes as Floor & Decor reported better-than-expected …

FND Q2 Deep Dive: Margin Expansion and Pro Sales Offset Vinyl Weakness

FND Q2 Deep Dive: Margin Expansion and Pro Sales Offset Vinyl Weakness Specialty flooring retailer Floor & Decor (NYSE:FND) reported Q2 CY2026 results exceeding the market's revenue expectations , with sales up 3% year on year to $1.25 billion. The company's full-year revenue guidance …

electroCore, Inc. (ECOR) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of electroCore, Inc. (ECOR), detailing its current valuation score, P/E ratio, and market capitalization. It highlights that the company's valuation score is 8.94, ranking 32nd in its industry, but notes that relevant data for P/B, P/S, and P/CF …

Azimut Holding (BIT:AZM) Stock Faces Margin Questions After Record AUM

Why Floor And Decor (FND) Stock Is Trading Up Today

Why Floor And Decor (FND) Stock Is Trading Up Today What Happened? Shares of specialty flooring retailer Floor & Decor (NYSE:FND) jumped 3.1% in the morning session after the company reported second-quarter results that beat Wall Street's expectations and provided a strong full-year outlook. …